Retroviral MDR1 gene transfer into marrow-engrafting human peripheral blood progenitor cells results in preferential transgene expression in the immature myeloid compartment rather than in mature myeloid progeny in vivo

References

• Moritz T, Williams DA. Marrow protection: transduction of hematopoietic cells with drug resistance genes. Cytotherapy 2001; 3: 67–84
   PubMed Web of Science ®Google Scholar
• Schiedlmeier B, Schilz AJ, Kuhlcke K, et al. Multidrug resistance 1 gene transfer can confer chemoprotection to human peripheral blood progenitor cells engrafted in immunodeficient mice. Hum Gene Ther 2002; 13: 233–42
   PubMed Web of Science ®Google Scholar
• Edelstein ML, Abedi MR, Wixon J, et al. Gene therapy clinical trials worldwide 1989–2004: an overview. J Gene Med 6; 2004: 597–602
   Google Scholar
• Li Z, Fehse B, Schiedlmeier B, et al. Persisting multilineage transgene expression in the clonal progeny of a hematopoietic stem cell. Leukemia 2002; 16: 1655–63
   PubMed Web of Science ®Google Scholar
• Hacein-Bey-Abina S, Le Deist F, Carlier F, et al. Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N Engl J Med 2002; 346: 1185–93
   PubMed Web of Science ®Google Scholar
• Hacein-Bey-Abina S, von Kalle C, Schmidt M, et al. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 2003; 348: 255–6
   PubMed Web of Science ®Google Scholar
• Dao MA, Tsark E, Nolta JA. Animal xenograft models for evaluation of gene transfer into human hematopoietic stem cells. Curr Opin Mol Ther 1999; 1: 553–7
   PubMed Web of Science ®Google Scholar
• Schiedlmeier B, Kühlcke K, Eckert HG, et al. Quantitative assessment of retroviral transfer of the human multidrug resistance 1 gene to human mobilized peripheral blood progenitor cells engrafted in nonobese diabetic/severe combined immunodeficient mice. Blood 2000; 95: 1237–48
   PubMed Web of Science ®Google Scholar
• Bunting KD, Galipeau J, Topham D, et al. Transduction of murine bone marrow cells with an MDR1 vector enables ex vivo stem cell expansion, but these expanded grafts cause a myeloproliferative syndrome in transplanted mice. Blood 1998; 92: 2269–79
   PubMed Web of Science ®Google Scholar
• Kiem HP, Sellers S, Thomasson B, et al. Long-term clinical and molecular follow-up of large animals receiving retrovirally transduced stem and progenitor cells: no progression to clonal hematopoiesis or leukemia. Mol Ther 2004; 9: 389–95
   PubMed Web of Science ®Google Scholar
• Sellers SE, Tisdale JF, Agricola BA, et al. The effect of multidrug-resistance 1 gene versus neo transduction on ex vivo and in vivo expansion of rhesus macaque hematopoietic repopulating cells. Blood 2001; 97: 1888–91
   PubMed Web of Science ®Google Scholar
• Guenechea G, Segovia JC, Albella B, et al. Delayed engraftment of nonobese diabetic/severe combined immunodeficient mice transplanted with ex vivo-expanded human CD34(+) cord blood cells. Blood 1999; 93: 1097–105
   PubMed Web of Science ®Google Scholar
• Horn PA, Topp MS, Morris JC, et al. Highly efficient gene transfer into baboon marrow repopulating cells using GALV-pseudotype oncoretroviral vectors produced by human packaging cells. Blood 2002; 100: 3960–7
   PubMed Web of Science ®Google Scholar
• Piacibello W, Bruno S, Sanavio F, et al. Lentiviral gene transfer and ex vivo expansion of human primitive stem cells capable of primary, secondary, and tertiary multilineage repopulation in NOD/SCID mice. Nonobese diabetic/severe combined immunodeficient. Blood 2002; 100: 4391–400
   PubMed Web of Science ®Google Scholar
• Klimecki WT, Futscher BW, Grogan TM, et al. P-glycoprotein expression and function in circulating blood cells from normal volunteers. Blood 1994; 83: 2451–8
   PubMed Web of Science ®Google Scholar
• Hildinger M, Abel KL, Ostertag W, et al. Design of 5′ untranslated sequences in retroviral vectors developed for medical use. J Virol 1999; 73: 4083–9
   PubMed Web of Science ®Google Scholar
• Knipper R, Kuehlcke K, Schiedlmeier B, et al. Improved post-transcriptional processing of an MDR1 retrovirus elevates expression of multidrug resistance in primary human hematopoietic cells. Gene Ther 2001; 8: 239–46
   PubMed Web of Science ®Google Scholar
• Eckert HG, Kuhlcke K, Schilz AJ, et al. Clinical scale production of an improved retroviral vector expressing the human multidrug resistance 1 gene (MDR1). Bone Marrow Transplant 2000; 25(Suppl 2)S114–17
   Google Scholar
• Schilz AJ, Schiedlmeier B, Kuhlcke K, et al. MDR1 gene expression in NOD/SCID repopulating cells after retroviral gene transfer under clinically relevant conditions. Mol Ther 2000; 2: 609–18
   PubMed Web of Science ®Google Scholar
• Fruehauf S, Breems DA, Knaan Shanzer S, et al. Frequency analysis of multidrug resistance-1 gene transfer into human primitive hematopoietic progenitor cells using the cobblestone area-forming cell assay and detection of vector-mediated P-glycoprotein expression by rhodamine-123. Hum Gene Ther 1996; 7: 1219–31
   PubMed Web of Science ®Google Scholar
• Li Z, Dullmann J, Schiedlmeier B, et al. Murine leukemia induced by retroviral gene marking. Science 2002; 296: 497
   PubMed Web of Science ®Google Scholar
• Seggewiss, R, Pittaluga, S, Adler, RL, , et al. Acute myeloid leukemia associated with retroviral gene transfer to hematopoietic progenitor cells of a rhesus macaque. Blood 2006;107:3865–7.
   PubMed Web of Science ®Google Scholar
• Woods NB, Bottero V, Schmidt M, et al. Gene therapy: therapeutic gene causing lymphoma. Nature 2006; 440: 1123
   PubMed Web of Science ®Google Scholar
• Hildinger M, Eckert HG, Schilz AJ, et al. FMEV vectors: both retroviral long terminal repeat and leader are important for high expression in transduced hematopoietic cells. Gene Ther 1998; 5: 1575–9
   PubMed Web of Science ®Google Scholar
• Laufs S, Gentner B, Nagy KZ, et al. Retroviral vector integration occurs in preferred genomic targets of human bone marrow-repopulating cells. Blood 2003; 101: 2191–8
   PubMed Web of Science ®Google Scholar
• Nagy, KZ, Laufs, S, Gentner, B, , et al. Clonal analysis of individual marrow-repopulating cells after PBPC transplantation. Stem Cells 2004;22:570–9.
   PubMed Web of Science ®Google Scholar
• Wermann K, Fruehauf S, Haas R, et al. Human–mouse xenografts in stem cell research. J Hematother 1996; 5: 379–90
   PubMedGoogle Scholar
• Barlogie B, Shaughnessy J, Tricot G, et al. Treatment of multiple myeloma. Blood 2004; 103: 20–32
   PubMed Web of Science ®Google Scholar
• Carpinteiro A, Peinert S, Ostertag W, et al. Genetic protection of repopulating hematopoietic cells with an improved MDR1-retrovirus allows administration of intensified chemotherapy following stem cell transplantation in mice. Int J Cancer 2002; 98: 785–92
   PubMed Web of Science ®Google Scholar
• Bunting KD. ABC transporters as phenotypic markers and functional regulators of stem cells. Stem Cells 2002; 20: 11–20
   PubMed Web of Science ®Google Scholar
• Schaich M, Soucek S, Thiede C, et al. MDR1 and MRP1 gene expression are independent predictors for treatment outcome in adult acute myeloid leukaemia. Br J Haematol 2005; 128: 324–32
   PubMed Web of Science ®Google Scholar
• van der HB, Lowenberg B, Burnett AK, et al. The value of the MDR1 reversal agent PSC-833 in addition to daunorubicin and cytarabine in the treatment of elderly patients with previously untreated acute myeloid leukemia (AML), in relation to MDR1 status at diagnosis. Blood 2005; 106: 2646–54
   PubMed Web of Science ®Google Scholar
• Neff T, Beard BC, Peterson LJ, et al. Polyclonal chemoprotection against temozolomide in a large-animal model of drug resistance gene therapy. Blood 2005; 105: 997–1002
   PubMed Web of Science ®Google Scholar